Treatment of COVID19 with antimalarial medicines: clinical pharmacology analysis
The COVID-19 epidemic caused by the human coronovirus has led to completely new challenges for clinical pharmacology, and the healthcare system as a whole. By the time the infection started, there was no effective and safe therapy. In this regard, at the request of the society and medical workers, c...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2020-10-01
|
| Series: | Клиническая микробиология и антимикробная химиотерапия |
| Subjects: | |
| Online Access: | https://cmac-journal.ru/publication/2020/3/cmac-2020-t22-n3-p164/cmac-2020-t22-n3-p164.pdf |